Heal & Go₂ Medical

Safety, risks and contraindications

What treatment involves

Hyperbaric oxygen therapy at Heal & Go₂ is delivered in a monoplace chamber, which means you are treated on your own rather than in a group.

Oxygen is delivered through a mask rather than into the chamber itself.

You will be given a medical cotton gown to change into before your session. This is a safety requirement rather than a formality, and is explained in full in your pre-treatment information.

Your chamber operator can see, hear and speak to you throughout, and you can speak to them at any point during the session.

Treatment is delivered at pressures between 2.0 and 2.4 ATA. The exact pressure, session duration and number of sessions vary by clinical indication and by the relevant treatment protocol.

Treatment pressure is not selected by the patient, and may differ between clinical indications.

A course typically runs from ten sessions up to sixty, with each session lasting between 60 and 120 minutes.

Every HBOT treatment at Heal & Go₂ is provided following a medical assessment and an individual prescription from a doctor trained in hyperbaric medicine.

A trained chamber operator supervises and continuously monitors you throughout the treatment, and is responsible for the safe operation of the chamber.

A registered nurse is available as part of the clinical team during treatment sessions, with appropriate medical cover and a defined escalation pathway should you become unwell or require medical review.

You will not undergo HBOT without trained clinical and chamber personnel responsible for your care.

What it is used for

Hyperbaric oxygen therapy is used for a defined set of clinical indications. Whether it is appropriate for you is a clinical decision taken after assessment, and it is not suitable for everyone.

This page covers safety, risks and what to expect. It does not set out which conditions are treated, or what treatment achieves for them. Those are covered on the individual condition pages, which are reviewed and approved separately.

Risks and side effects

Repeated hyperbaric oxygen therapy can sometimes cause a temporary change in vision, most commonly a short-sighted or myopic shift.

This effect is usually temporary and reversible, with vision gradually returning towards its previous level after the course of HBOT has finished. You should not be alarmed if you notice a mild change in distance vision during a course of treatment.

If you are undertaking a planned course of repeated HBOT, we record your baseline visual acuity before treatment begins, so that any subsequent change can be assessed against it.

A routine formal ophthalmology or optometry assessment is not required for every patient, but may be recommended for those with pre-existing eye disease, significant visual impairment or other relevant clinical concerns.

Please let the clinical team know if you notice any change in your vision during treatment. Any significant, persistent or unusual visual symptoms will be clinically assessed and, where appropriate, referred for further ophthalmic evaluation.

We advise you not to drive yourself home after your first HBOT session. Where possible, please arrange alternative transport. This gives you a chance to understand how you personally respond to treatment.

After subsequent sessions you may drive, provided you feel completely well and have no dizziness, light-headedness, significant fatigue, visual disturbance or other symptoms that could impair safe driving.

If any of these symptoms occur, do not drive until they have fully resolved.

If you experience changes in vision during a course of treatment, please make sure your vision remains suitable for safe driving, and discuss any significant change with the clinical team.

UK driving guidance similarly treats disabling dizziness and functionally significant visual impairment as incompatible with safe driving until recovery.

Contraindications

Hyperbaric oxygen therapy is not suitable for everyone. Before treatment begins, every patient undergoes a medical assessment to identify anything that could make treatment unsafe or require additional precautions.

Absolute

UNTREATED PNEUMOTHORAX (collapsed lung) is an absolute contraindication to HBOT. If an untreated pneumothorax is known or suspected, treatment will not proceed.

Relative

Other medical conditions are considered relative contraindications. This means they do not automatically prevent treatment, but they require individual assessment by the hyperbaric medical team before HBOT can be prescribed.

Please tell us if you have, or have previously had:

  • a lung condition, particularly one associated with air trapping, lung blebs or bullae, or a previous spontaneous pneumothorax
  • recent chest or thoracic surgery
  • a current cold, chest infection, blocked nose, sinus infection or significant sinus problems
  • difficulty equalising pressure in your ears or sinuses, or previous significant ear surgery or ear disease
  • epilepsy, seizures or a previous history of seizures
  • significant heart disease, particularly heart failure
  • a fever or current acute illness
  • claustrophobia, significant anxiety or panic in enclosed spaces
  • recent eye surgery, particularly where gas has been introduced into the eye
  • pregnancy, or think you may be pregnant
  • an implanted medical device, such as a pacemaker, ICD, neurostimulator or other pressure-sensitive or electronic device
  • any other significant medical condition that could affect your ability to tolerate changes in pressure or increased oxygen exposure.

Medicines and previous treatments

Please provide us with a complete and up-to-date list of your medicines and tell us about any recent or previous chemotherapy or cancer treatment.

Certain medicines and treatments require additional consideration before HBOT. This does not necessarily mean that you cannot receive treatment. The hyperbaric doctor will consider the medicine or treatment involved, when it was given and your individual circumstances before deciding whether HBOT can safely proceed.

Implanted medical devices

Having an implanted medical device does not automatically prevent you from receiving HBOT.

The clinical team will need to establish that the device is suitable for use under the pressure and oxygen conditions required for your treatment. Where necessary, compatibility will be confirmed with the manufacturer or relevant specialist team before treatment proceeds.

What a relative contraindication means

Having a relative contraindication does not automatically mean that you cannot have HBOT.

It means that we need to assess the potential risks and benefits in your individual circumstances. Additional investigations, specialist advice, additional precautions or postponement of treatment may occasionally be required.

Following assessment, the hyperbaric doctor will decide whether treatment can safely proceed and whether any additional precautions are necessary.

Who should not have treatment

Hyperbaric oxygen affects several body systems, so certain conditions, recent procedures and medications need to be assessed before treatment.

Please tell the clinical team about:

  • any lung condition, or a recent chest infection, cold or blocked sinuses
  • recent ear, sinus, dental, chest or abdominal surgery
  • any implanted medical device
  • all current medications, including anything recently started or changed
  • pregnancy, or if you may be pregnant
  • previous difficulty with pressure changes, including on flights
  • claustrophobia or a history of panic attacks

Some conditions mean HBOT is not suitable. Others simply need managing before you start. Either way, the assessment exists to make treatment safe for you, and being straightforward with the team is the most useful thing you can do.

Clinical and advertising approval
Approved 4 September 2026 · Dr Anil Dasineni
Reviewed by
Dr Anil Dasineni, MBBS, DNB (Emergency Medicine), MRCEM. Registered with the General Medical Council with a licence to practise.
Last reviewed
4 September 2026
Next review due
4 September 2027
Clinical tier
Tier 1
Clinical determination
Medical Director, Heal & Go₂ screening list, 27 August 2026.

Clinically governed and CQC-aligned. Heal & Go₂ Medical is working towards CQC registration and does not describe itself as CQC registered.